Repository logo
 

Potential Retinal Biomarkers in Alzheimer's Disease.

Published version
Peer-reviewed

Repository DOI


Change log

Authors

García-Bermúdez, Mariana Yolotzin  ORCID logo  https://orcid.org/0000-0001-8652-5374
Wijngaarden, Peter van  ORCID logo  https://orcid.org/0000-0002-8800-7834

Abstract

Alzheimer's disease (AD) represents a major diagnostic challenge, as early detection is crucial for effective intervention. This review examines the diagnostic challenges facing current AD evaluations and explores the emerging field of retinal alterations as early indicators. Recognizing the potential of the retina as a noninvasive window to the brain, we emphasize the importance of identifying retinal biomarkers in the early stages of AD. However, the examination of AD is not without its challenges, as the similarities shared with other retinal diseases introduce complexity in the search for AD-specific markers. In this review, we address the relevance of using the retina for the early diagnosis of AD and the complex challenges associated with the search for AD-specific retinal biomarkers. We provide a comprehensive overview of the current landscape and highlight avenues for progress in AD diagnosis by retinal examination.

Description

Peer reviewed: True


Publication status: Published


Funder: Department of Drug Design and Pharmacology at the University of Copenhagen


Funder: Savværksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat

Journal Title

Int J Mol Sci

Conference Name

Journal ISSN

1661-6596
1422-0067

Volume Title

24

Publisher

MDPI

Rights and licensing

Except where otherwised noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/
Sponsorship
Novo Nordisk Foundation (NNF18SA0034956)
Foundation for Research in Neurology and Innovation Foundation Denmark (2078-00002B)
ILF group (859376)